Literature DB >> 34695274

Cerebellar pathology and disability worsening in relapsing-remitting multiple sclerosis: A retrospective analysis from the CombiRx trial.

Maria Petracca1,2, Gary Cutter3, Sirio Cocozza1,4, Leorah Freeman5, John Kangarlu1, Monica Margoni1,6, Matteo Moro1,7, Stephen Krieger1, Mohamed Mounir El Mendili1,8, Amgad Droby1,9,10,11, Jerry S Wolinsky12, Fred Lublin1, Matilde Inglese1,13,14.   

Abstract

BACKGROUND AND
PURPOSE: Cerebellar damage is a valuable predictor of disability, particularly in progressive multiple sclerosis. It is not clear if it could be an equally useful predictor of motor disability worsening in the relapsing-remitting phenotype. AIM: We aimed to determine whether cerebellar damage is an equally useful predictor of motor disability worsening in the relapsing-remitting phenotype.
METHODS: Cerebellar lesion loads and volumes were estimated using baseline magnetic resonance imaging from the CombiRx trial (n = 838). The relationship between cerebellar damage and time to disability worsening (confirmed disability progression [CDP], timed 25-foot walk test [T25FWT] score worsening, nine-hole peg test [9HPT] score worsening) was tested in stagewise and stepwise Cox proportional hazards models, accounting for demographics and supratentorial damage.
RESULTS: Shorter time to 9HPT score worsening was associated with higher baseline Expanded Disability Status Scale (EDSS) score (hazard ratio [HR] 1.408, p = 0.0042) and higher volume of supratentorial and cerebellar T2 lesions (HR 1.005 p = 0.0196 and HR 2.211, p = 0.0002, respectively). Shorter time to T25FWT score worsening was associated with higher baseline EDSS (HR 1.232, p = 0.0006). Shorter time to CDP was associated with older age (HR 1.026, p = 0.0010), lower baseline EDSS score (HR 0.428, p < 0.0001) and higher volume of supratentorial T2 lesions (HR 1.024, p < 0.0001).
CONCLUSION: Among the explored outcomes, single time-point evaluation of cerebellar damage only allows the prediction of manual dexterity worsening. In clinical studies the selection of imaging biomarkers should be informed by the outcome of interest.
© 2021 European Academy of Neurology.

Entities:  

Keywords:  cerebellar damage; clinical trials; magnetic resonance imaging; manual dexterity; multiple sclerosis

Mesh:

Year:  2021        PMID: 34695274     DOI: 10.1111/ene.15157

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  1 in total

1.  A prospective study to validate the expanded timed get-up-and-go in a population with multiple sclerosis.

Authors:  Dejan Jakimovski; Katelyn S Kavak; Karen Zakalik; Lacey Bromley; Osman Ozel; Natasha Qutab; Svetlana P Eckert; Channa Kolb; Bianca Weinstock-Guttman
Journal:  Mult Scler J Exp Transl Clin       Date:  2022-05-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.